The Delhi government’s drug control department has directed pharmacy owners across the national capital to refrain from selling Coldrif cough syrup. The development comes days after at least more than 20 children from Madhya Pradesh’s Chhindwara district died after consuming the syrup manufactured by Tamil Nadu-based Sresan Pharmaceuticals.

The order issued said that the drug Coldrif Syrup has been declared as ‘not of standard quality’ by the Government Analyst, Drugs Testing Laboratory, Food and Drugs Administration, Madhya Pradesh, and the formulation is allegedly adulterated as it contains diethylene glycol (46.28% w/v), which makes the drug formulation injurious to health.

“In view of this, as a precautionary measure, all the stakeholders are hereby directed to refrain from dealing i

See Full Page